1.1 Research Scope 1.2 Market Segmentation 1.3 Research Objectives 1.4 Research Methodology 1.4.1 Research Process 1.4.2 Data Triangulation 1.4.3 Research Approach 1.4.4 Base Year 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.5.2 Covid-19 Impact: Commodity Prices Indices 1.5.3 Covid-19 Impact: Global Major Government Policy 1.6 The Covid-19 Impact on Biogenic Stimulant Industry 1.7 COVID-19 Impact: Biogenic Stimulant Market Trends 2 Global Biogenic Stimulant Quarterly Market Size Analysis 2.1 Biogenic Stimulant Business Impact Assessment - COVID-19 2.1.1 Global Biogenic Stimulant Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.1.2 Global Biogenic Stimulant Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 2.2 Global Biogenic Stimulant Quarterly Market Size 2020-2021 2.3 COVID-19-Driven Market Dynamics and Factor Analysis 2.3.1 Drivers 2.3.2 Restraints 2.3.3 Opportunities 2.3.4 Challenges 3 Quarterly Competitive Assessment, 2020 3.1 Global Biogenic Stimulant Quarterly Market Size by Manufacturers, 2019 VS 2020 3.2 Global Biogenic Stimulant Factory Price by Manufacturers 3.3 Location of Key Manufacturers Biogenic Stimulant Manufacturing Factories and Area Served 3.4 Date of Key Manufacturers Enter into Biogenic Stimulant Market 3.5 Key Manufacturers Biogenic Stimulant Product Offered 3.6 Mergers & Acquisitions, Expansion Plans 4 Impact of Covid-19 on Biogenic Stimulant Segments, By Type 4.1 Introduction 1.4.1 Humic Substances 1.4.2 Seaweed Extracts 1.4.3 Microbial Amendments 1.4.4 Trace Minerals 1.4.5 Vitamins & Amino Acids 1.4.6 Others 4.2 By Type, Global Biogenic Stimulant Market Size, 2019-2021 4.2.1 By Type, Global Biogenic Stimulant Market Size by Type, 2020-2021 4.2.2 By Type, Global Biogenic Stimulant Price, 2020-2021 5 Impact of Covid-19 on Biogenic Stimulant Segments, By Application 5.1 Overview 5.5.1 Foilar 5.5.2 Soil 5.5.3 Seed 5.2 By Application, Global Biogenic Stimulant Market Size, 2019-2021 5.2.1 By Application, Global Biogenic Stimulant Market Size by Application, 2019-2021 5.2.2 By Application, Global Biogenic Stimulant Price, 2020-2021 6 Geographic Analysis 6.1 Introduction 6.2 North America 6.2.1 Macroeconomic Indicators of US 6.2.2 US 6.2.3 Canada 6.3 Europe 6.3.1 Macroeconomic Indicators of Europe 6.3.2 Germany 6.3.3 France 6.3.4 UK 6.3.5 Italy 6.4 Asia-Pacific 6.4.1 Macroeconomic Indicators of Asia-Pacific 6.4.2 China 6.4.3 Japan 6.4.4 South Korea 6.4.5 India 6.4.6 ASEAN 6.5 Rest of World 6.5.1 Latin America 6.5.2 Middle East and Africa 7 Company Profiles 7.1 BASF SE 7.1.1 BASF SE Business Overview 7.1.2 BASF SE Biogenic Stimulant Quarterly Production and Revenue, 2020 7.1.3 BASF SE Biogenic Stimulant Product Introduction 7.1.4 BASF SE Response to COVID-19 and Related Developments 7.2 Dow AgroSciences 7.2.1 Dow AgroSciences Business Overview 7.2.2 Dow AgroSciences Biogenic Stimulant Quarterly Production and Revenue, 2020 7.2.3 Dow AgroSciences Biogenic Stimulant Product Introduction 7.2.4 Dow AgroSciences Response to COVID-19 and Related Developments 7.3 Dupont 7.3.1 Dupont Business Overview 7.3.2 Dupont Biogenic Stimulant Quarterly Production and Revenue, 2020 7.3.3 Dupont Biogenic Stimulant Product Introduction 7.3.4 Dupont Response to COVID-19 and Related Developments 7.4 Novozymes A/S 7.4.1 Novozymes A/S Business Overview 7.4.2 Novozymes A/S Biogenic Stimulant Quarterly Production and Revenue, 2020 7.4.3 Novozymes A/S Biogenic Stimulant Product Introduction 7.4.4 Novozymes A/S Response to COVID-19 and Related Developments 7.5 Isagro SAP 7.5.1 Isagro SAP Business Overview 7.5.2 Isagro SAP Biogenic Stimulant Quarterly Production and Revenue, 2020 7.5.3 Isagro SAP Biogenic Stimulant Product Introduction 7.5.4 Isagro SAP Response to COVID-19 and Related Developments 7.6 Sapec Group 7.6.1 Sapec Group Business Overview 7.6.2 Sapec Group Biogenic Stimulant Quarterly Production and Revenue, 2020 7.6.3 Sapec Group Biogenic Stimulant Product Introduction 7.6.4 Sapec Group Response to COVID-19 and Related Developments 7.7 Platform Specialty Products Corporation 7.7.1 Platform Specialty Products Corporation Business Overview 7.7.2 Platform Specialty Products Corporation Biogenic Stimulant Quarterly Production and Revenue, 2020 7.7.3 Platform Specialty Products Corporation Biogenic Stimulant Product Introduction 7.7.4 Platform Specialty Products Corporation Response to COVID-19 and Related Developments 7.8 Biolchim S.P.A 7.8.1 Biolchim S.P.A Business Overview 7.8.2 Biolchim S.P.A Biogenic Stimulant Quarterly Production and Revenue, 2020 7.8.3 Biolchim S.P.A Biogenic Stimulant Product Introduction 7.8.4 Biolchim S.P.A Response to COVID-19 and Related Developments 7.9 Valagro SAP 7.9.1 Valagro SAP Business Overview 7.9.2 Valagro SAP Biogenic Stimulant Quarterly Production and Revenue, 2020 7.9.3 Valagro SAP Biogenic Stimulant Product Introduction 7.9.4 Valagro SAP Response to COVID-19 and Related Developments 7.10 Koppert B.V 7.10.1 Koppert B.V Business Overview 7.10.2 Koppert B.V Biogenic Stimulant Quarterly Production and Revenue, 2020 7.10.3 Koppert B.V Biogenic Stimulant Product Introduction 7.10.4 Koppert B.V Response to COVID-19 and Related Developments 7.11 Biostadt India Limited 7.11.1 Biostadt India Limited Business Overview 7.11.2 Biostadt India Limited Biogenic Stimulant Quarterly Production and Revenue, 2020 7.11.3 Biostadt India Limited Biogenic Stimulant Product Introduction 7.11.4 Biostadt India Limited Response to COVID-19 and Related Developments 7.12 Italpollina SAP 7.12.1 Italpollina SAP Business Overview 7.12.2 Italpollina SAP Biogenic Stimulant Quarterly Production and Revenue, 2020 7.12.3 Italpollina SAP Biogenic Stimulant Product Introduction 7.12.4 Italpollina SAP Response to COVID-19 and Related Developments 7.13 Huma Gro 7.13.1 Huma Gro Business Overview 7.13.2 Huma Gro Biogenic Stimulant Quarterly Production and Revenue, 2020 7.13.3 Huma Gro Biogenic Stimulant Product Introduction 7.13.4 Huma Gro Response to COVID-19 and Related Developments 8 Supply Chain and Sales Channels Analysis 8.1 Biogenic Stimulant Supply Chain Analysis 8.1.1 Biogenic Stimulant Supply Chain Analysis 8.1.2 Covid-19 Impact on Biogenic Stimulant Supply Chain 8.2 Distribution Channels Analysis 8.2.1 Biogenic Stimulant Distribution Channels 8.2.2 Covid-19 Impact on Biogenic Stimulant Distribution Channels 8.2.3 Biogenic Stimulant Distributors 8.3 Biogenic Stimulant Customers 9 Key Findings 10 Appendix 10.1 About Us 10.2 Disclaimer

List of Tables Table 1. Overview of the World Economic Outlook Projections Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity) Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise) Table 7. Covid-19 Impact: Global Major Government Policy Table 8. The Covid-19 Impact on Biogenic Stimulant Assessment Table 9. COVID-19 Impact: Biogenic Stimulant Market Trends Table 10. COVID-19 Impact Global Biogenic Stimulant Market Size Table 11. Global Biogenic Stimulant Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT) Table 12. Global Biogenic Stimulant Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT) Table 13. Global Biogenic Stimulant Quarterly Market Size, 2020 (US$ Million) & (K MT) Table 14. Global Biogenic Stimulant Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million) Table 15. Global Biogenic Stimulant Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT) Table 16. Global Biogenic Stimulant Market Growth Drivers Table 17. Global Biogenic Stimulant Market Restraints Table 18. Global Biogenic Stimulant Market Opportunities Table 19. Global Biogenic Stimulant Market Challenges Table 20. Key Manufacturers Biogenic Stimulant Quarterly Revenue, 2019 VS 2020 (US$ Million) Table 21. Top Manufacturers, Biogenic Stimulant Market Size, 2019 (K MT) & (US$ Million) Table 22. Biogenic Stimulant Factory Price by Manufacturers 2020 (USD/MT) Table 23. Location of Key Manufacturers Biogenic Stimulant Manufacturing Plants Table 24. Key Manufacturers Biogenic Stimulant Market Served Table 25. Date of Key Manufacturers Enter into Biogenic Stimulant Market Table 26. Key Manufacturers Biogenic Stimulant Product Type Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Biogenic Stimulant Market Size by Type, 2020, (US$ Million) Table 29. Global Biogenic Stimulant Market Size by Type, 2020 (K MT) Table 30. Global Biogenic Stimulant Price: by Type, 2020-2021 (USD/MT) Table 31. Global Biogenic Stimulant Market Size by Application: 2020-2021 (US$ Million) Table 32. Global Biogenic Stimulant Market Size by Application, 2020-2021 (K MT) Table 33. Global Biogenic Stimulant Price: by Application, 2020-2021 (USD/MT) Table 34. Global Biogenic Stimulant Market Size by Region, 2019-2021 (US$ Million) Table 35. Global Biogenic Stimulant Market Size by Region, 2019-2021 (K MT) Table 36. By Country, North America Biogenic Stimulant Market Size, 2019-2021 (US$ Million) Table 37. By Country, North America Biogenic Stimulant Market Size, 2019-2021 (K MT) Table 38. US Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 39. Canada Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy) Table 41. By Country, Europe Biogenic Stimulant Market Size, 2019-2021 (US$ Million) Table 42. By Country, Europe Biogenic Stimulant Market Size, 2019-2021 (K MT) Table 43. Germany Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 44. France Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 45. UK Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 46. Italy Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN) Table 48. By Region, Asia-Pacific Biogenic Stimulant Market Size, 2019-2021 (US$ Million) Table 49. By Region, Asia-Pacific Biogenic Stimulant Market Size, 2019-2021 (K MT) Table 50. China Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 51. Japan Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 52. South Korea Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 53. India Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 54. ASEAN Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 55. Latin America Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 56. Middle East and Africa Biogenic Stimulant Market Size, 2019-2021 (US$ Million) & (K MT) Table 57. BASF SE Business Overview Table 58. BASF SE Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 59. BASF SE Biogenic Stimulant Product Table 60. BASF SE Response to COVID-19 and Related Developments Table 61. Dow AgroSciences Business Overview Table 62. Dow AgroSciences Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 63. Dow AgroSciences Biogenic Stimulant Product Table 64. Dow AgroSciences Response to COVID-19 and Related Developments Table 65. Dupont Business Overview Table 66. Dupont Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 67. Dupont Biogenic Stimulant Product Table 68. Dupont Response to COVID-19 and Related Developments Table 69. Novozymes A/S Business Overview Table 70. Novozymes A/S Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 71. Novozymes A/S Biogenic Stimulant Product Table 72. Novozymes A/S Response to COVID-19 and Related Developments Table 73. Isagro SAP Business Overview Table 74. Isagro SAP Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 75. Isagro SAP Biogenic Stimulant Product Table 76. Isagro SAP Response to COVID-19 and Related Developments Table 77. Sapec Group Business Overview Table 78. Sapec Group Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 79. Sapec Group Biogenic Stimulant Product Table 80. Sapec Group Response to COVID-19 and Related Developments Table 81. Platform Specialty Products Corporation Business Overview Table 82. Platform Specialty Products Corporation Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 83. Platform Specialty Products Corporation Biogenic Stimulant Product Table 84. Platform Specialty Products Corporation Response to COVID-19 and Related Developments Table 85. Biolchim S.P.A Business Overview Table 86. Biolchim S.P.A Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 87. Biolchim S.P.A Biogenic Stimulant Product Table 88. Biolchim S.P.A Response to COVID-19 and Related Developments Table 89. Valagro SAP Business Overview Table 90. Valagro SAP Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 91. Valagro SAP Biogenic Stimulant Product Table 92. Valagro SAP Response to COVID-19 and Related Developments Table 93. Koppert B.V Business Overview Table 94. Koppert B.V Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 95. Koppert B.V Biogenic Stimulant Product Table 96. Koppert B.V Response to COVID-19 and Related Developments Table 97. Biostadt India Limited Business Overview Table 98. Biostadt India Limited Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 99. Biostadt India Limited Biogenic Stimulant Product Table 100. Biostadt India Limited Response to COVID-19 and Related Developments Table 101. Italpollina SAP Business Overview Table 102. Italpollina SAP Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 103. Italpollina SAP Biogenic Stimulant Product Table 104. Italpollina SAP Response to COVID-19 and Related Developments Table 105. Huma Gro Business Overview Table 106. Huma Gro Biogenic Stimulant Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020 Table 107. Huma Gro Biogenic Stimulant Product Table 108. Huma Gro Response to COVID-19 and Related Developments Table 109. Biogenic Stimulant Distributors List Table 110. Biogenic Stimulant Customers List Table 111. Covid-19 Impact on Biogenic Stimulant Customers List of Figures Figure 1. Biogenic Stimulant Product Picture Figure 2. Biogenic Stimulant Market Segmentation Figure 3. Research Objectives Figure 4. Research Process Figure 5. Data Triangulation Figure 6. Research Approach Figure 7. Commodity Prices-Metals Price Indices Figure 8. Commodity Prices- Precious Metal Price Indices Figure 9. Commodity Prices- Agricultural Raw Material Price Indices Figure 10. Commodity Prices- Food and Beverage Price Indices Figure 11. Commodity Prices- Fertilizer Price Indices Figure 12. Commodity Prices- Energy Price Indices Figure 13. G20+: Economic Policy Responses to COVID-19 Figure 14. Global Biogenic Stimulant Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million) Figure 15. Global Biogenic Stimulant Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%) Figure 16. Global Biogenic Stimulant Market Size, Quarterly Growth, 2020-2021 (%) Figure 17. Global Biogenic Stimulant Market Size, Market Share by Type, 2019 VS 2020 (%) Figure 18. Global Biogenic Stimulant Market Size, Market Share by Application, 2019 VS 2020 (%) Figure 19. Global Biogenic Stimulant Market Size Market Share by Region, 2019 VS 2020 (%) Figure 20. United States Composite PMI and GDP Figure 21. Eurozone Composite PMI and GDP Figure 22. Eurozone Core v. Periphery PMI Output Indices Figure 23. Core v. Periphery PMI Employment Indices Figure 24. UK Composite PMI and GDP Figure 25. Caixin China Composite Output Index Figure 26. Caixin China General Services Business Activity Index Figure 27. Japan Composite Output Index Figure 28. South Korea Manufacturing PMI Figure 29. India Composite Output Index Figure 30. ASEAN Manufacturing PMI Figure 31. By Region, Asia-Pacific Biogenic Stimulant Market Size Market Share, 2019-2021

BASF SE Dow AgroSciences Dupont Novozymes A/S Isagro SAP Sapec Group Platform Specialty Products Corporation Biolchim S.P.A Valagro SAP Koppert B.V Biostadt India Limited Italpollina SAP Huma Gro